Marketed By
Hetero Healthcare Ltd
Pack of
30 tablets
Salt Composition
Emtricitabine and Tenofovir Alafenamide
Storage
Keep in cold place
Delivering To: —
Overview
Tafero EM is a generic medication containing emtricitabine and tenofovir alafenamide and is intended for use in adults and adolescents above 12 years old with a body weight equal to or greater than 35 kilograms. Tafero EM is administered orally on a daily basis, with or without food, and acts as a reverse transcriptase inhibitor, thereby preventing replication of HIV‑1.
Not only does Tafero EM prevent the spread of infection along with other antiretroviral medicines, but it may also be used as a form of PrEP (pre‑exposure prophylaxis) for those individuals who have an increased risk of being infected. Although not a cure for HIV, Tafero EM provides effective control and enhances the immune response of an individual.
Indication
HIV Infection
Uses
HIV infection treatment
Side Effects
The following are the possible side effects that can occur during your treatment with Tafero-EM. Contact your medical practitioner immediately if any of the above-mentioned side effects appear.
- Nausea and vomiting
- Diarrhea
- Headache
- Fatigue
- Insomnia (difficulty sleeping)
- Fever and cough
- Liver function abnormalities
- Allergic reactions
- Reactivation of Hepatitis B
- Increased risk of bone fractures
- Acute kidney failure
Dosage and Administration
The recommended dose of Tafero EM medicine is decided by a doctor according to your previous medical condition and response to the treatment. Do not take this medicine in the wrong way, as it may lead to some serious side effects. Take the tablet at the same time each day, with food, and swallow it whole with water; do not split, chew, or crush it.
Mechanism of action
Emtricitabine (Tafero EM), a synthetic nucleoside analog of cytidine, is phosphorylated by cellular enzymes to form emtricitabine 5'-triphosphate. Emtricitabine inhibits the activity of the HIV-1 reverse transcriptase (RT) by competing with the natural substrate deoxycytidine 5'-triphosphate and by being incorporated into nascent viral DNA, which results in chain termination.
Safety Advice
Alcohol
UNSAFE
Pregnancy
CONSULT YOUR DOCTOR
Breast Feeding
CONSULT YOUR DOCTOR
Driving
DANGER
Kidney
PRECAUTION
Liver
PRECAUTION
Missed Doses
If you miss a dose of Tafero EM take it as soon as you remember. If it’s nearly time for your next scheduled dose, skip the missed one and continue with your regular routine. Do not take two tablets at once to make up for the missed dose.
FAQs
Tafero EM tablet is an antiviral medication that prevents the human immunodeficiency virus (HIV) from multiplying in your body. It also helps to delay the progression of HIV infection and improves the quality of life
This medication helps to boost your immune system to fight against infection and also increases the CD4 cell (white blood cells that protect against infection) count in your blood.
The effectiveness of Tafero EM Tablet in lowering women's risk of getting HIV has not been thoroughly studied. If you are a woman, speak with your doctor before using this medication.
Tafero-EM tablet is available in the strength of 200mg/25mg.
If you miss a scheduled dose of Tafero EM tablets, take it as soon as you remember. If it’s nearly time for your next scheduled dose, skip the missed one and continue with your regular routine. Do not take two tablets at once to make up for the missed dose. Contact your doctor for any query.
Tafero EM Tablet does not appear to interact with grapefruit or grapefruit juice. But it's always a good idea to talk to your healthcare professional about any dietary issues or possible problems.
Follow your doctor’s advice about any restrictions on food and other activities.
References
- Ali, S. H., Shah, M. H., Roy, S., Bharadwaj, H. R., Tan, J. K., Rao, M. S., Dalal, P. (2025). Efficacy and safety of tenofovir plus entecavir combination therapy versus tenofovir monotherapy in chronic hepatitis B virus patients with resistance or partial response to entecavir. Journal of Clinical and Experimental Hepatology, 15(4), 102541. PubMed+1PubMed+1 - https://pubmed.ncbi.nlm.nih.gov/40248347/
- Efficacy and safety of tenofovir and entecavir in patients with chronic hepatitis B-related cirrhosis. (2025). Frontiers in Pharmacology, 16, 1507117. PMC+1PubMed+1 - https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1507117/full
- Tenofovir alafenamide fumarate, tenofovir disoproxil fumarate, and entecavir: Which is the Most Effective Drug for Chronic Hepatitis B? A Systematic Review and Meta‑analysis. (2025). Journal of Viral Hepatitis & Hepatology.
Ratings And Reviews
4.86/5
7 Ratings
5 Star
85.71%
4 Star
14.29%
3 Star
0.00%
2 Star
0.00%
1 Star
0.00%
Preeti M.
Works better than expected
a year ago
Isha S.
Highly recommended
a year ago
View All Reviews
Related Products
MARKETER DETAILS
Hetero Healthcare Ltd
DISCLAIMER
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.